SIG
58
-2
DRI
64
4
EXPE
74
2
HES
59
3
GOOGL
53
2
MS
50
-8
RIG
35
-3
AKAM
56
-2
PLD
51
-5
AEP
59
-3
INTC
37
-4
CMG
50
-6
MSI
69
-3
COST
51
-3
AN
49
2
ES
55
-5
SPG
53
-2
O
35
-2
MA
65
-4
SRE
54
-5
SIG
58
-2
DRI
64
4
EXPE
74
2
HES
59
3
GOOGL
53
2
MS
50
-8
RIG
35
-3
AKAM
56
-2
PLD
51
-5
AEP
59
-3
INTC
37
-4
CMG
50
-6
MSI
69
-3
COST
51
-3
AN
49
2
ES
55
-5
SPG
53
-2
O
35
-2
MA
65
-4
SRE
54
-5
Financhill
Back

Plus Therapeutics Quote, Financials, Valuation and Earnings

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager
Sell
21

PSTV
Plus Therapeutics

Last Price:
1.57
Seasonality Move:
-9.88%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Plus Therapeutics Price Quote

$1.57
-0.08 (-4.79%)
(Updated: September 19, 2024 at 6:10 PM ET)

Plus Therapeutics Key Stats

Sell
21
Plus Therapeutics (PSTV) is a Sell
Day range:
$1.60 - $1.76
52-week range:
$0.97 - $2.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.50
P/B ratio:
0%
Volume:
79.5K
Avg. volume:
47K
1-year change:
24.92%
Market cap:
$9.7M
Revenue:
$0
EPS:
$-3.16

How Much Does Plus Therapeutics Make?

Data Unavailable

Is Plus Therapeutics Growing As A Company?

Data Unavailable

Plus Therapeutics Stock Price Performance

What Is Plus Therapeutics 52-Week High & Low?

Plus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Plus Therapeutics?

  • How Much Debt Does Plus Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Plus Therapeutics Have?
    Cash and short term investments quarterly total is $8.4M
  • What Is Plus Therapeutics’s Book Value Per Share?
    Book value per share is -1.34

Is Plus Therapeutics Cash Flow Positive?

  • What Is PSTV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.9M
  • What Is Plus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.2M
  • What Is Plus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.2M

Plus Therapeutics Return On Invested Capital

Data Unavailable

Plus Therapeutics Earnings Date & Stock Price

Plus Therapeutics Competitors

  • Who Are Plus Therapeutics's Competitors?
    Below is a list of companies who compete with Plus Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Plus Therapeutics Dividend Yield

Plus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.09%
Revenue: 0% 14.54%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.00
Upside from Last Price: 870.29%

Major Shareholders

  • How many PSTV shares are owned by institutional investors?
    735.9K PSTV shares are owned by institutional investors
  • How many PSTV shares are owned by insiders?
    1.2M PSTV shares are owned by insiders